Solriamfetol for teens with ADHD
Part of Mental health clinical trials.
This study tests a new medicine, solriamfetol, to see if it helps teenagers with ADHD. The medicine is taken as a tablet and may improve focus and reduce symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 12 and under 18 years old.
- You have been diagnosed with ADHD by a doctor.
- You are willing to take a study tablet daily.
- Your parent or guardian agrees to sign a consent form, and you agree to sign an assent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a medication called solriamfetol can safely help children with ADHD. If your child is between 6 and 12 years old and has ADHD, this study may be an option.
This study checks the long-term safety of the drug solriamfetol for attention-deficit/hyperactivity disorder (ADHD) in children and adolescents who have already completed an earlier study of this medication.
This study tests whether a fecal microbiota transplant (FMT) - a treatment that puts healthy gut bacteria into the body - can help reduce ADHD symptoms in teenagers who are already on medication. The goal is to see if improving gut health can improve brain and behavior.
This study helps personalise ADHD medication for children and young people on waiting lists. It aims to find the best treatment plan for each child, potentially making medication more effective and reducing side effects.
This trial tests a new brain stimulation method (iTBS) targeting two areas of the brain to help teens with ADHD who haven't improved enough with medication. It aims to see if this approach is safe and effective.
This study tests whether brain wave recordings (EEG) can help predict how well children with ADHD will respond to stimulant medications. It aims to find the best treatment faster, potentially reducing the guesswork in choosing the right medication.
Hear when a new ADHD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.